Metaraminol, metoxamine and angiotensin II are other vasoconstrictor agents which are used in clinical practice; fewer clinical trials have been carried out on them and they have few advantages regarding their effectiveness and safety compared to ephedrine or phenylephrine.6
El metaraminol, la metoxamina y la angiotensina II son otros vasopresores que se usan en la práctica clínica con menos pruebas clíncas y sin ventajas en su efectividad o seguridad, comparados con la efedrina o la fenilefrina.6